Table Info

Table 1.

Diseases associated with gastrointestinal (GI) eosinophilia for each eosinophilic GI disease (EGID)

EGID	Related diseases
Eosinophilic esophagitis (EoE) [12]	Achalasia
	Crohn disease
	Celiac disease
	Parasitic infection
	Idiopathic hypereosinophilic syndrome (HES)
	Vasculitis
	Drug hypersensitivity
	Connective tissue disease
	Gastroesophageal reflux disease (GERD)
Eosinophilic gastritis (EoG) and eosinophilic enteritis (EoN) [64, 65]	Malignancy
	Crohn disease
	Celiac disease
	Helicobacter pylori
	Autoimmune gastritis
	Radiation enteritis
	Drug reaction
Eosinophilic colitis (EoC) [40, 65, 66]	Inflammatory bowel disease (IBD)
	Crohn disease
	Celiac disease
	Helminthic infections (e.g., pin worms, hookworms)
	Idiopathic HES
	Autoimmune diseases (scleroderma, Churg-Strauss)
	Drug reaction

Declarations

Author contributions

GP and AP: Conceptualization, Investigation, Writing—original draft, Writing—review & editing. AB: Validation, Writing—review & editing. ACS and NR: Validation, Writing—review & editing, Supervision. All authors read and approved the submitted version.

Conflicts of interest

Nikoletta Rovina who is the Guest Editor of Exploration of Asthma & Allergy had no involvement in the decision-making or the review process of this manuscript. The other authors declare that they have no conflicts of interest.

Ethical approval

Not applicable.

Consent to participate

Not applicable.

Consent to publication

Not applicable.

Availability of data and materials

Not applicable.

Funding

Not applicable.

Copyright

References

Dellon ES, Gonsalves N, Abonia JP, Alexander JA, Arva NC, Atkins D, et al. International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature. Clin Gastroenterol Hepatol. 2022;20:2474–84.e3. [DOI] [PubMed] [PMC]

Collins MH, Capocelli K, Yang GY. Eosinophilic Gastrointestinal Disorders Pathology. Front Med (Lausanne). 2018;4:261. [DOI] [PubMed] [PMC]

Lam AY, Gonsalves N. “Tickle me pink”: update in eosinophilic gastrointestinal disorders. Curr Opin Gastroenterol. 2023;39:36–42. [DOI] [PubMed]

Muir A, Falk GW. Eosinophilic Esophagitis: A Review. JAMA. 2021;326:1310–8. [DOI] [PubMed] [PMC]

Underwood B, Troutman TD, Schwartz JT. Breaking down the complex pathophysiology of eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2023;130:28–39. [DOI] [PubMed] [PMC]

Rothenberg ME, Spergel JM, Sherrill JD, Annaiah K, Martin LJ, Cianferoni A, et al. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet. 2010;42:289–91. [DOI] [PubMed] [PMC]

Chang X, March M, Mentch F, Nguyen K, Glessner J, Qu H, et al. A genome-wide association meta-analysis identifies new eosinophilic esophagitis loci. J Allergy Clin Immunol. 2022;149:988–98. [DOI] [PubMed] [PMC]

Sleiman PM, Wang ML, Cianferoni A, Aceves S, Gonsalves N, Nadeau K, et al. GWAS identifies four novel eosinophilic esophagitis loci. Nat Commun. 2014;5:5593. [DOI] [PubMed] [PMC]

Alexander ES, Martin LJ, Collins MH, Kottyan LC, Sucharew H, He H, et al. Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis. J Allergy Clin Immunol. 2014;134:1084–92.e1. [DOI] [PubMed] [PMC]

10.

Jensen ET, Kuhl JT, Martin LJ, Langefeld CD, Dellon ES, Rothenberg ME. Early-life environmental exposures interact with genetic susceptibility variants in pediatric patients with eosinophilic esophagitis. J Allergy Clin Immunol. 2018;141:632–7.e5. [DOI] [PubMed] [PMC]

11.

Busing JD, Buendia M, Choksi Y, Hiremath G, Das SR. Microbiome in Eosinophilic Esophagitis-Metagenomic, Metatranscriptomic, and Metabolomic Changes: A Systematic Review. Front Physiol. 2021;12:731034. [DOI] [PubMed] [PMC]

12.

Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128:3–20.e6. [DOI] [PubMed]

13.

Spechler SJ. Eosinophilic esophagitis: novel concepts regarding pathogenesis and clinical manifestations. J Gastroenterol. 2019;54:837–44. [DOI] [PubMed] [PMC]

14.

Dellon ES, Hirano I. Epidemiology and Natural History of Eosinophilic Esophagitis. Gastroenterology. 2018;154:319–32.e3. [DOI] [PubMed] [PMC]

15.

Furuta GT, Liacouras CA, Collins MH, Gupta SK, Justinich C, Putnam PE, et al.; First International Gastrointestinal Eosinophil Research Symposium (FIGERS) Subcommittees. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342–63. [DOI] [PubMed]

16.

Ferguson AE, Mukkada VA, Fulkerson PC. Pediatric Eosinophilic Esophagitis Endotypes: Are We Closer to Predicting Treatment Response? Clin Rev Allergy Immunol. 2018;55:43–55. [DOI] [PubMed] [PMC]

17.

Furuta GT, Katzka DA. Eosinophilic Esophagitis. N Engl J Med. 2015;373:1640–8. [DOI] [PubMed] [PMC]

18.

Sherrill JD, Kc K, Wu D, Djukic Z, Caldwell JM, Stucke EM, et al. Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis. Mucosal Immunol. 2014;7:718–29. [DOI] [PubMed] [PMC]

19.

Inage E, Furuta GT, Menard-Katcher C, Masterson JC. Eosinophilic esophagitis: pathophysiology and its clinical implications. Am J Physiol Gastrointest Liver Physiol. 2018;315:G879–86. [DOI] [PubMed] [PMC]

20.

Bolton SM, Kagalwalla AF, Wechsler JB. Eosinophilic Esophagitis in Children: Endoscopic Findings at Diagnosis and Post-intervention. Curr Gastroenterol Rep. 2018;20:4. [DOI] [PubMed] [PMC]

21.

Khokhar D, Marella S, Idelman G, Chang JW, Chehade M, Hogan SP. Eosinophilic esophagitis: Immune mechanisms and therapeutic targets. Clin Exp Allergy. 2022;52:1142–56. [DOI] [PubMed] [PMC]

22.

Blanchard C, Mingler MK, Vicario M, Abonia JP, Wu YY, Lu TX, et al. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol. 2007;120:1292–300. [DOI] [PubMed]

23.

Hirano I, Dellon ES, Hamilton JD, Collins MH, Peterson K, Chehade M, et al. Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis. Gastroenterology. 2020;158:111–22.e10. [DOI] [PubMed]

24.

Spechler SJ. Gastroesophageal Reflux Disease and Eosinophilic Esophagitis. Gastroenterol Hepatol (N Y). 2019;15:111–3. [PubMed] [PMC]

25.

Doyle AD, Masuda MY, Kita H, Wright BL. Eosinophils in Eosinophilic Esophagitis: The Road to Fibrostenosis is Paved With Good Intentions. Front Immunol. 2020;11:603295. [DOI] [PubMed] [PMC]

26.

Reed CC, Wolf WA, Cotton CC, Rusin S, Perjar I, Hollyfield J, et al. Optimal Histologic Cutpoints for Treatment Response in Patients With Eosinophilic Esophagitis: Analysis of Data From a Prospective Cohort Study. Clin Gastroenterol Hepatol. 2018;16:226–33.e2. [DOI] [PubMed] [PMC]

27.

Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N, et al. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Gastroenterology. 2018;155:1022–33.e10. [DOI] [PubMed] [PMC]

28.

Molina-Infante J, Mata-Romero P, Martín-Holgado D. New approaches to diet therapy for eosinophilic esophagitis. Curr Opin Gastroenterol. 2023;39:315–9. [DOI] [PubMed]

29.

Spergel J, Aceves SS. Allergic components of eosinophilic esophagitis. J Allergy Clin Immunol. 2018;142:1–8. [DOI] [PubMed] [PMC]

30.

Hill DA, Dudley JW, Spergel JM. The Prevalence of Eosinophilic Esophagitis in Pediatric Patients with IgE-Mediated Food Allergy. J Allergy Clin Immunol Pract. 2017;5:369–75. [DOI] [PubMed] [PMC]

31.

Katsoulis K, Tryfon S. Questions and answers: About the use of omalizumab in clinical practice. Pneumon. 2017;30:92–6.

32.

Dellon ES, Spergel JM. Biologics in eosinophilic gastrointestinal diseases. Ann Allergy Asthma Immunol. 2023;130:21–7. [DOI] [PubMed] [PMC]

33.

Wąsik J, Małecka-Wojciesko E. Eosinophilic Esophagitis—What Do We Know So Far? J Clin Med. 2023;12:2259. [DOI] [PubMed] [PMC]

34.

Egan M, Atkins D. What Is the Relationship Between Eosinophilic Esophagitis (EoE) and Aeroallergens? Implications for Allergen Immunotherapy. Curr Allergy Asthma Rep. 2018;18:43. [DOI] [PubMed] [PMC]

35.

Mishra A, Hogan SP, Brandt EB, Rothenberg ME. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest. 2001;107:83–90. [DOI] [PubMed] [PMC]

36.

Akei HS, Mishra A, Blanchard C, Rothenberg ME. Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice. Gastroenterology. 2005;129:985–94. [DOI] [PubMed]

37.

Rochman M, Azouz NP, Rothenberg ME. Epithelial origin of eosinophilic esophagitis. J Allergy Clin Immunol. 2018;142:10–23. [DOI] [PubMed] [PMC]

38.

Robey BS, Eluri S, Reed CC, Jerath MR, Hernandez ML, Commins SP, et al. Subcutaneous immunotherapy in patients with eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2019;122:532–3.e3. [DOI] [PubMed] [PMC]

39.

Jensen ET, Martin CF, Kappelman MD, Dellon ES. Prevalence of Eosinophilic Gastritis, Gastroenteritis, and Colitis: Estimates From a National Administrative Database. J Pediatr Gastroenterol Nutr. 2016;62:36–42. [DOI] [PubMed] [PMC]

40.

Papadopoulou A, Amil-Dias J, Auth MK, Chehade M, Collins MH, Gupta SK, et al. Joint ESPGHAN/NASPGHAN Guidelines on Childhood Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr. 2024;78:122–52. [DOI] [PubMed]

41.

Kinoshita Y, Oouchi S, Fujisawa T. Eosinophilic gastrointestinal diseases – Pathogenesis, diagnosis, and treatment. Allergol Int. 2019;68:420–9. [DOI] [PubMed]

42.

Pesek RD, Reed CC, Muir AB, Fulkerson PC, Menard-Katcher C, Falk GW, et al.; Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR). Increasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data Across a Multicenter Consortium. Am J Gastroenterol. 2019;114:984–94. [DOI] [PubMed] [PMC]

43.

Shoda T, Wen T, Caldwell JM, Collins MH, Besse JA, Osswald GA, et al.; Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR). Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study. J Allergy Clin Immunol. 2020;145:255–69. [DOI] [PubMed] [PMC]

44.

Walker MM, Potter MD, Talley NJ. Eosinophilic colitis and colonic eosinophilia. Curr Opin Gastroenterol. 2019;35:42–50. [DOI] [PubMed]

45.

Impellizzeri G, Marasco G, Eusebi LH, Salfi N, Bazzoli F, Zagari RM. Eosinophilic colitis: A clinical review. Dig Liver Dis. 2019;51:769–73. [DOI] [PubMed]

46.

Shoda T, Collins MH, Rochman M, Wen T, Caldwell JM, Mack LE, et al.; Consortium of Eosinophilic Gastrointestinal Diseases Researchers (CEGIR). Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study. Gastroenterology. 2022;162:1635–49. [DOI] [PubMed] [PMC]

47.

Gonsalves NP, Aceves SS. Diagnosis and treatment of eosinophilic esophagitis. J Allergy Clin Immunol. 2020;145:1–7. [DOI] [PubMed] [PMC]

48.

Hirano I, Chan ES, Rank MA, Sharaf RN, Stollman NH, Stukus DR, et al.; AGA Institute Clinical Guidelines Committee; Joint Task Force on Allergy-Immunology Practice Parameters. AGA institute and the joint task force on allergy-immunology practice parameters clinical guidelines for the management of eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2020;124:416–23. [DOI] [PubMed] [PMC]

49.

Miehlke S, Lucendo AJ, Straumann A, Jan Bredenoord A, Attwood S. Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence. Therap Adv Gastroenterol. 2020;13:1756284820927282. [DOI] [PubMed] [PMC]

50.

Ishimura N, Ishihara S, Kinoshita Y. Sustained Acid Suppression by Potassium-Competitive Acid Blocker (P-CAB) May Be An Attractive Treatment Candidate for Patients with Eosinophilic Esophagitis. Am J Gastroenterol. 2016;111:1203–4. [DOI] [PubMed]

51.

Główczewski A, Krogulska A. Formulations of Topical Steroids in Eosinophilic Esophagitis—Current Treatment and Emerging Possibilities. J Clin Med. 2022;11:1454. [DOI] [PubMed] [PMC]

52.

Syverson EP, Tobin M, Patton T, Franciosi JP, Gupta SK, Venkatesh RD. Variability in Swallowed Topical Corticosteroid Practice Patterns for Treatment of Pediatric Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr. 2023;77:256–9. [DOI] [PubMed]

53.

Ellepola AN, Samaranayake LP. Inhalational and topical steroids, and oral candidosis: a mini review. Oral Dis. 2001;7:211–6. [DOI] [PubMed]

54.

Chen JW. Management of Eosinophilic Esophagitis: Dietary and Nondietary Approaches. Nutr Clin Pract. 2020;35:835–47. [DOI] [PubMed]

55.

Arias A, González-Cervera J, Tenias JM, Lucendo AJ. Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis. Gastroenterology. 2014;146:1639–48. [DOI] [PubMed]

56.

Mayerhofer C, Kavallar AM, Aldrian D, Lindner AK, Müller T, Vogel GF. Efficacy of Elimination Diets in Eosinophilic Esophagitis: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2023;21:2197–210.e3. [DOI] [PubMed]

57.

Gaertner WB, Macdonald JE, Kwaan MR, Shepela C, Madoff R, Jessurun J, et al. Eosinophilic colitis: university of Minnesota experience and literature review. Gastroenterol Res Pract. 2011;2011:857508. [DOI] [PubMed] [PMC]

58.

Egritas Gurkan O, Ozturk H, Karagol HIE, Ceylan K, Duztas DT, Ekinci O, et al. Primary Eosinophilic Gastrointestinal Diseases Beyond Eosinophilic Esophagitis in Children. J Pediatr Gastroenterol Nutr. 2021;72:294–9. [DOI] [PubMed]

59.

Dellon ES, Rothenberg ME, Collins MH, Hirano I, Chehade M, Bredenoord AJ, et al. Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis. N Engl J Med. 2022;387:2317–30. [DOI] [PubMed]

60.

U.S. Food and Drug Administration. FDA Approves First Treatment for Eosinophilic Esophagitis, a Chronic Immune Disorder [Internet]. Cision US Inc.; 2024 [cited 2023 Jul 20]. Available from: https://www.prnewswire.com/news-releases/fda-approves-first-treatment-for-eosinophilic-esophagitis-a-chronic-immune-disorder-301552266.html

61.

Straumann A. Biologics in Eosinophilic Esophagitis — Ready for Prime Time? N Engl J Med. 2022;387:2379–80. [DOI] [PubMed]

62.

Nhu QM, Aceves SS. Current state of biologics in treating eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2023;130:15–20. [DOI] [PubMed]

63.

Kostikas K, Bakakos P, Galanakis P, Hillas G, Konstantinou GN, Makris M, et al. Capturing patient-centered outcomes using innovative technologies in adults with severe eosinophilic asthma on benralizumab: The EMPOWAIR real-world study design. Pneumon. 2022;35:24. [DOI]

64.

Zuo L, Rothenberg ME. Gastrointestinal eosinophilia. Immunol Allergy Clin North Am. 2007;27:443–55. [DOI] [PubMed] [PMC]

65.

Yantiss RK. Eosinophils in the GI tract: how many is too many and what do they mean? Mod Pathol. 2015;28:S7–21. [DOI] [PubMed]

66.

Alfadda AA, Storr MA, Shaffer EA. Eosinophilic colitis: epidemiology, clinical features, and current management. Therap Adv Gastroenterol. 2011;4:301–9. [DOI] [PubMed] [PMC]